Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.
about
TNF-alpha inhibitors for ankylosing spondylitisLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisIndustry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statinsComparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological studyNetwork meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosisOptimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysisUK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concernsComparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological studyThirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-AnalysisRisk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.GetReal in network meta-analysis: a review of the methodology.Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials.Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data.Incorporation of individual-patient data in network meta-analysis for multiple continuous endpoints, with application to diabetes treatment.Bayesian network meta-analysis for unordered categorical outcomes with incomplete data.Bayesian model selection for meta-analysis of diagnostic test accuracy data: Application to Ddimer for deep vein thrombosis.Network meta-analysis of individual and aggregate level data.A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisonsA graphical tool for locating inconsistency in network meta-analyses.An overview of methods for network meta-analysis using individual participant data: when do benefits arise?Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain.The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee: network meta-analysis.Indirect comparisons: a review of reporting and methodological qualityA process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancerNetwork meta-analysis of survival data with fractional polynomials.Tocolytic therapy for preterm delivery: systematic review and network meta-analysisEfficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysisSimulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons.Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes.Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers.Comparative effectiveness of anti-VEGF agents for diabetic macular edema.Multiple treatment comparison meta-analyses: a step forward into complexity.An assessment of the methodological quality of published network meta-analyses: a systematic review.Network meta-analysis of longitudinal data using fractional polynomials.Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies.The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-AnalysisTriptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses.A general framework for comparative Bayesian meta-analysis of diagnostic studies.
P2860
Q24186462-A032221D-3DE9-40BC-B8AE-9669508B5C65Q24197853-0CA171BB-0383-4303-B064-8A0EB8704125Q24289041-83CF7174-29C2-4D4D-8D60-3E85B8C739F2Q26782126-DAF3A501-E777-42A3-9E0A-73E68D2F1F9DQ26824664-9E98C1B6-1616-47A6-B3CD-AEA49F1FB4BCQ28087211-72E1FF39-873A-43A8-A5FD-51089878D63DQ28601297-C55B8DED-55D1-4CFA-8F66-3F47F4A42773Q28677533-29304582-BD11-4D04-9CEB-BAB2884E8A2EQ30239022-C561D8BC-C0B0-4A48-9553-A7B1D650C7B9Q30245390-38DB231A-9E05-48C8-9294-977A2885E376Q30251972-8CEC3363-B528-44BA-8643-9F8CB9BE89D7Q30567158-F2AC6A0C-2141-4837-88CC-1F3595E7615CQ30850451-168E04E0-0080-4EAF-9B88-563751DA92D5Q30940503-7AF4D5F5-9EC8-4841-AA65-402A7B5D1A29Q30967626-5F0EFCEE-5FD7-459F-BAC9-117B0DC9D810Q30969075-3283550E-FD38-4B8A-8904-FE571C3A0E49Q30969336-1AFA86E1-F3AE-455C-B1BF-E3704E3AE604Q31017575-995AAD30-2B80-47B9-BB9B-69D41EF41F1BQ31112914-E1BBE86A-463B-4D0F-AC6C-51A32663A984Q31119372-ED67224F-BED1-480B-B00C-B7238B3361EAQ31135481-FA79D9A8-C29F-44E6-BA12-150EDD091056Q33556721-EF7E4522-7A09-41B8-BBCA-6C0CD4C92CA9Q33685276-7CBCEBB2-44E6-44B8-A4DF-F6CD215BF67CQ33750311-587A1BD6-D172-4036-975F-0C260E96526CQ33830562-40AC43F1-D12F-47F8-91BD-45F5FD2BD316Q33891529-CEE0005B-3A8C-4433-8302-785E62C950C8Q34304826-E550F569-AF55-4C6A-9D70-567C33910AC5Q34316776-A7445673-D9EA-4BA7-A20B-F47FBB39EE81Q34413025-7E6DB584-610A-4D0A-8815-DCC6A2EC8A17Q34436139-60EACBC4-824C-43FE-A3F9-252387223DD7Q34798269-24523DA7-1F97-4FF0-AF79-09441CE0C498Q35056819-D1E862F8-4FC6-4CFF-85B5-E6A46F18C5B2Q35089776-66625C7D-D070-4570-AEE2-0C7472BC8B6EQ35553233-31DDC8C0-797D-4AD9-A33F-5FCFE35663BAQ35602850-81A3239F-57AB-46F6-88A3-08F8A205D54FQ35612977-77EB2187-EBF2-4747-9830-7834A3736372Q35677315-5B9D7FA8-D43F-4277-AB7F-F169FF3780BCQ35692944-52BBCD5D-FAB8-4D4A-AE2C-BEC153E8725BQ35752782-AE6F9392-734C-4CD2-A704-FC7CD414142EQ35758192-C8D49B6D-A5CC-4E8E-9D03-C9487DB82F54
P2860
Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Addressing between-study heter ...... rheumatic atrial fibrillation.
@en
Addressing between-study heter ...... rheumatic atrial fibrillation.
@nl
type
label
Addressing between-study heter ...... rheumatic atrial fibrillation.
@en
Addressing between-study heter ...... rheumatic atrial fibrillation.
@nl
prefLabel
Addressing between-study heter ...... rheumatic atrial fibrillation.
@en
Addressing between-study heter ...... rheumatic atrial fibrillation.
@nl
P2093
P356
P1476
Addressing between-study heter ...... rheumatic atrial fibrillation.
@en
P2093
Alex J Sutton
Danielle Morris
Nicola J Cooper
P2860
P304
P356
10.1002/SIM.3594
P407
P577
2009-06-01T00:00:00Z